| Jinnah, H A; Hess, Ellen J (2008) Experimental therapeutics for dystonia. Neurotherapeutics 5:198-209 |
| Kock, Norman; Naismith, Teresa V; Boston, Heather E et al. (2006) Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier. Hum Mol Genet 15:1355-64 |
| Hewett, Jeffrey W; Zeng, Juan; Niland, Brian P et al. (2006) Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol Dis 22:98-111 |
| Kock, Norman; Allchorne, Andrew J; Sena-Esteves, Miguel et al. (2006) RNAi blocks DYT1 mutant torsinA inclusions in neurons. Neurosci Lett 395:201-5 |
| Siegert, S; Bahn, E; Kramer, M L et al. (2005) TorsinA expression is detectable in human infants as young as 4 weeks old. Brain Res Dev Brain Res 157:19-26 |
| Sharma, Nutan; Baxter, Mark G; Petravicz, Jeremy et al. (2005) Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J Neurosci 25:5351-5 |
| Augood, Sarah J; Hollingsworth, Z; Albers, David S et al. (2004) Dopamine transmission in DYT1 dystonia. Adv Neurol 94:53-60 |
| Hewett, Jeffrey W; Kamm, Christoph; Boston, Heather et al. (2004) TorsinB--perinuclear location and association with torsinA. J Neurochem 89:1186-94 |
| Grandi, Paola; Wang, Samuel; Schuback, Deborah et al. (2004) HSV-1 virions engineered for specific binding to cell surface receptors. Mol Ther 9:419-27 |
| Bragg, D C; Camp, S M; Kaufman, C A et al. (2004) Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors. Neuroscience 125:651-61 |
Showing the most recent 10 out of 56 publications
